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Introduction
We report a case of toxic megacolon (TM) associated with
fulminant pseudomembranous colitis (PMC). When a patient
is unable to tolerate subtotal colectomy and ileostomy because
of a severe overall condition, then a temporary colostomy
followed by administration of vancomycin through the stoma
is recommended.
Case report
A 72-year-old female underwent closure of a sigmoid colos-
tomy on 12 February, 1997. Cefotiam 1,000 mg intravenously
(iv) twice daily was administered postoperatively for 6 days.
From the 15th postoperative day, both imipenem and ofloxacin
were given because of a low-grade fever. After the patient
improved, she was discharged and demonstrated a normal
bowel function on 15 March. Six days later, the patient noted
the onset of abdominal distension. She was readmitted to our
hospital with severe dehydration. She was pale, thirsty and
hypothermal (33.6°C). Her blood pressure was 60 mmHg and
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pulse rate was 120–140/minute. Her abdomen was markedly
distended and rebound tenderness was mild. Bowel sounds
were diminished. The white blood cell count was 55,100/mm3.
Computed tomography (CT) showed diffuse colonic wall
thickening, marked oedema, and dilatation of the transverse
colon (7 cm) with ascites (Figure 1A). Intravenous fluid re-
placement was started and she was observed while receiving
conservative therapy. The next day, her general condition
further deteriorated and she underwent emergency surgery.
No preoperative colonoscopy was performed. About 2 L of
yellowish clear fluid filled the peritoneal sac. From the appen-
dix to the sigmoid colon, the wall of the colon was thickened,
oedematous and distended. Systolic blood pressure was
40 mmHg and pulse rate was 100/minute during the operation.
The patient was not considered strong enough to tolerate a
subtotal colectomy with an ileostomy, and thus a transverse
colostomy was performed. The colonic mucosa was entirely
covered with a confluent, yellowish plaque. A biopsy specimen
of the mucosa of the transverse colon demonstrated typical
PMC (Figure 2). However, stool culture and toxin assay were
negative for Clostridium difficile and other organisms. From the
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■ COLOSTOMY WITH VANCOMYCIN ADMINISTRATION ■
part of the colon (> 5.5 or 6 cm in diameter) with associated
systemic toxicity.4,5 This definition does not specify the under-
lying disease process. In our case, the temperature was 33.6°C,
the pulse rate was 120–140/minute, the white blood cell count
was 55,100/mm3, and CT showed doughnut-like ascending
and descending colons with dilatation of the transverse colon.
These data were closely correlated with the criteria for TM,
except for the temperature. Although prompt colonoscopy
together with biopsy normally leads to a rapid diagnosis, and
a subtotal colectomy with ileostomy is the most commonly
recommended surgical procedure, our patient was not able to
tolerate these procedures. Therefore, transverse colostomy
was performed. Though stool culture and toxin assay were
negative for both Clostridium difficile and its toxin, biopsy speci-
men from the mucosa of the transverse colon was typical of
PMC. Due to the fact that patients who undergo only colos-
tomy show an increased risk of mortality,4 vancomycin was
given postoperatively through the stoma. The patient showed
dramatic clinical improvement following surgery. We there-
fore recommend that colostomy combined with postopera-
tive injection of vancomycin from the stoma is indicated as a
definitive treatment for severe cases of TM associated with
fulminant PMC and shock.
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first postoperative day, vancomycin, 500 mg twice daily,
was injected via the distal loop from the stoma for 23 days, and
500 mg were also given four times daily by an oral or naso-
gastric tube to deliver to the proximal colon from the first
postoperative day for 48 days. Two months later, the diffuse
colonic wall thickening, colonic dilatation and ascites were
found to have disappeared according to abdominal CT (Fig-
ure 1B). The patient was thereafter discharged with a normally
functioning transverse colostomy.
Discussion
TM is a serious clinical entity usually identified as a complica-
tion of inflammatory bowel disease, ulcerative colitis, and
PMC. TM is rarely associated with PMC, and the previously
reported cases have often been grouped together with cases of
fulminant colitis and/or perforation caused by PMC.1–3 The
criteria for the diagnosis of TM are as follows: a temperature of
more than 38.5°C, a pulse of more than 120/minute, leucocy-
tosis of more than 10,500/mm3, and acute dilatation of all or
Figure 2. Biopsy specimen of the transverse colon shows a pseu-
domembrane (arrows) and inflammatory cells throughout.
Figure 1. Computed tomography shows: A) preoperative diffuse
colonic wall thickening and dilatation (arrows); B) that the diffuse
colonic wall thickening, colonic dilatation and ascites have disap-
peared 2 months later.
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